JPS58429B2 - Synquina 2-oxo-1,2,3,4-tetrahydropyride (2,3-D) Pyrimidine - Google Patents

Synquina 2-oxo-1,2,3,4-tetrahydropyride (2,3-D) Pyrimidine

Info

Publication number
JPS58429B2
JPS58429B2 JP49091202A JP9120274A JPS58429B2 JP S58429 B2 JPS58429 B2 JP S58429B2 JP 49091202 A JP49091202 A JP 49091202A JP 9120274 A JP9120274 A JP 9120274A JP S58429 B2 JPS58429 B2 JP S58429B2
Authority
JP
Japan
Prior art keywords
group
oxo
pyrimidine
lower alkyl
melting point
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP49091202A
Other languages
Japanese (ja)
Other versions
JPS5123296A (en
Inventor
井出博之
宮田悟
中川晃
本村敏治
野田寛治
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hisamitsu Pharmaceutical Co Inc
Original Assignee
Hisamitsu Pharmaceutical Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co Inc filed Critical Hisamitsu Pharmaceutical Co Inc
Priority to JP49091202A priority Critical patent/JPS58429B2/en
Priority to NL7506720A priority patent/NL7506720A/en
Priority to SE7506575A priority patent/SE420609B/en
Priority to CH815975A priority patent/CH614207A5/en
Priority to CA75230890A priority patent/CA1048496A/en
Publication of JPS5123296A publication Critical patent/JPS5123296A/en
Publication of JPS58429B2 publication Critical patent/JPS58429B2/en
Expired legal-status Critical Current

Links

Landscapes

  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

【発明の詳細な説明】 本発明は一般式(1) (式中、R1は(1)フェニル基、(2)ハロゲン原子
、低級アルキル基、低級アルコキシ基、ニトロ基又トリ
フルオロメチル基で置換されたフェニル基を、R2は(
1)水素原子、(2)低級アルキル基、(3)ハロゲン
原子、低級シクロアルキル基、水酸基、アルコキシ基、
アセトキシ基、フェニル基、アミノ基で置換された低級
アルキル基、(4)アルケニル基又は(5)アルキニル
基を意味する)で表わされる新規な2−オキソ−1,2
,3,4−テトラヒドロピリド〔2゜3−d〕ピリミジ
ン誘導体及びその酸付加塩の製造法に関するものである
Detailed Description of the Invention The present invention is based on the general formula (1) (wherein R1 is substituted with (1) a phenyl group, (2) a halogen atom, a lower alkyl group, a lower alkoxy group, a nitro group or a trifluoromethyl group) The phenyl group, R2 is (
1) hydrogen atom, (2) lower alkyl group, (3) halogen atom, lower cycloalkyl group, hydroxyl group, alkoxy group,
A novel 2-oxo-1,2 represented by an acetoxy group, a phenyl group, a lower alkyl group substituted with an amino group, (4) alkenyl group, or (5) alkynyl group)
, 3,4-tetrahydropyrido[2<3-d]pyrimidine derivatives and acid addition salts thereof.

更に詳しくは一般式(…) (式中、R1及びR2は前記と同じ意味を有する)で表
わされる化合物に一般式(I[D XCOY (HD (式中、Xはハロゲン原子、アルコキシ基及びアミノ基
を、Yはハロゲン原子、トリハロアルキル基、アルコキ
シ基、アリールオキシ基、アルコキシカルボニルオキシ
基、アシルオキシ基及びアミノ基を意味する)で表わさ
れる化合物を反応させ、前記一般式(1)で表わされる
化合物を製造する方法に関するものである。
More specifically, a compound represented by the general formula (...) (wherein R1 and R2 have the same meanings as above) is added to a compound represented by the general formula (I[D (Y means a halogen atom, trihaloalkyl group, alkoxy group, aryloxy group, alkoxycarbonyloxy group, acyloxy group, or amino group) is reacted with a compound represented by the above general formula (1). The present invention relates to a method for producing a compound.

前記一般式(I)及び(II)におけるR1及びR2に
就いて更に詳しく説明すると R1はフェニル基又は塩
素、臭素、弗素、沃素等のハロゲン原子、メチル、エチ
ル、n−プロピル、イソプロピル等の低級アルキル基、
メトキシ、エトキシ、プロポキシ等の低級アルコキシ基
、ニトロ基及びトリフルオロメチル基等が任意の位置に
1〜2個置換したフェニル基を R2の低級アルキル基
はメチル、エチル、n−プロピル、イソプロピル、n−
ブチルイソブチル、n−ペンチル等の低級アルキル基を
置換された低級アルキル基はハロゲン原子、低級シクロ
アルキル基、水酸基、アルコキシ基、アセトキシ基、フ
ェニル基又はアミノ基で置換された低級アルキル基を、
アルケニル基はアリル、3−メチルアリル、3,3−ジ
メチルアリル等を、アルキニル基はプロパルギル等を表
わす。
To explain R1 and R2 in the general formulas (I) and (II) in more detail, R1 is a phenyl group, a halogen atom such as chlorine, bromine, fluorine, or iodine, or a lower group such as methyl, ethyl, n-propyl, or isopropyl. alkyl group,
The lower alkyl group of R2 is a phenyl group substituted with one or two lower alkoxy groups such as methoxy, ethoxy, propoxy, nitro group, trifluoromethyl group, etc. at any position.The lower alkyl group of R2 is methyl, ethyl, n-propyl, isopropyl, n −
A lower alkyl group substituted with a lower alkyl group such as butyl isobutyl, n-pentyl, etc. is a lower alkyl group substituted with a halogen atom, a lower cycloalkyl group, a hydroxyl group, an alkoxy group, an acetoxy group, a phenyl group, or an amino group.
The alkenyl group represents allyl, 3-methylallyl, 3,3-dimethylallyl, etc., and the alkynyl group represents propargyl, etc.

又、一般式(2)におけるX及びYに就いて更に詳細に
説明すると、Xのハロゲン原子は塩素、臭素等を、アル
コキシ基はメトキシ、エトキシ等の低級アルコキシ基を
、アミノ基はイミダゾリル、トリアゾリル等の含窒素異
項環基を表わす。
Further, to explain X and Y in general formula (2) in more detail, the halogen atom of X is chlorine, bromine, etc., the alkoxy group is a lower alkoxy group such as methoxy or ethoxy, and the amino group is imidazolyl or triazolyl. represents a nitrogen-containing heterocyclic group such as

更にYのハロゲン原子及びアルコキシ基はXのそれと同
じ意味を有し、トリハロアルキル基は塩素、臭素等のハ
ロゲン原子で置換されたメチル基を、アルコキシカルボ
ニルオキシ基はメトキシカルボニルオキシ、エトキシカ
ルボニルオキシ等の低級アルコキシカルボニルオキシ基
を、アシルオキシ基はアセトキシ、トリハロゲノアセト
キシ等のアシルオキシ基を、アミノ基は2級低級アルキ
ルアミノ基(例えば、ジメチルアミノ、ジエチルアミノ
等)及び含窒素異項環基(例えば、イミダゾール、1゜
2.3−トリアゾール等)を表わす。
Further, the halogen atom and alkoxy group of Y have the same meaning as that of X, the trihaloalkyl group is a methyl group substituted with a halogen atom such as chlorine or bromine, and the alkoxycarbonyloxy group is methoxycarbonyloxy, ethoxycarbonyloxy, etc. The acyloxy group is an acyloxy group such as acetoxy or trihalogenoacetoxy, and the amino group is a secondary lower alkylamino group (e.g., dimethylamino, diethylamino, etc.) or a nitrogen-containing heterocyclic group (e.g., imidazole, 1°2,3-triazole, etc.).

本発明の出発原料である一般式(II)の化合物は2−
アミノニコチン酸アミド誘導体をリチウムアルミニウム
ハイドライド、ナトリウム水素化ビス(2−メトキシエ
トキシ)アルミニウム等で還元することによって得られ
る。
The compound of general formula (II) which is the starting material of the present invention is 2-
It is obtained by reducing an aminonicotinamide derivative with lithium aluminum hydride, sodium bis(2-methoxyethoxy)aluminum hydride, or the like.

本発明を反応式で示すと次の通りである。The reaction formula of the present invention is as follows.

本発明はジグリム、テトラヒドロフラン、ジオキサン、
ベンゼン、トルエン、キシレン、ジメチルホルムアミド
、エチルアルコール等の反応に関与しない有機溶媒中、
ナトリウムアミド、水素化ナトリウム、ナトリウムエチ
ラート等の金属化合物、ピリジン、トリメチルアミノ、
トリエチルアミノ等の有機塩基、酢酸ナトリウム、酢酸
カリウム等の有機酸のアルカリ金属塩又は水酸化アルカ
リ、炭酸アルカリ等の無機塩基の存在下一般式(It)
で表わされる化合物と一般仝@)で表わされる化合物を
反応させることによって行なわれる。
The present invention uses diglyme, tetrahydrofuran, dioxane,
In organic solvents that do not participate in the reaction, such as benzene, toluene, xylene, dimethylformamide, ethyl alcohol, etc.
Metal compounds such as sodium amide, sodium hydride, sodium ethylate, pyridine, trimethylamino,
General formula (It) in the presence of an organic base such as triethylamino, an alkali metal salt of an organic acid such as sodium acetate or potassium acetate, or an inorganic base such as alkali hydroxide or alkali carbonate.
This is carried out by reacting a compound represented by () with a compound represented by (general).

特に前記金属化合物を使用すると収量よく目的化合物を
得ることができる。
In particular, when the above metal compounds are used, the target compound can be obtained in good yield.

又、R2が水素原子の場合及び反応試薬としてN 、
N′−カルボニルジイミダゾールを使用する場合は無触
媒下でも反応は進行する。
In addition, when R2 is a hydrogen atom and N as a reaction reagent,
When N'-carbonyldiimidazole is used, the reaction proceeds even in the absence of a catalyst.

反応温度は特に限定されないが通常使用する溶媒の沸点
か又は沸点近くで行なうと反応時間は短縮される。
The reaction temperature is not particularly limited, but the reaction time will be shortened if the reaction is carried out at or near the boiling point of the commonly used solvent.

反応生成物は減圧上溶媒を留去し残渣をエーテル、メタ
ノール等の有機溶媒で再結晶するか又はカラムクロマト
法によって分離精製することによって純品を得ることが
できる。
A pure product can be obtained from the reaction product by distilling off the solvent under reduced pressure and recrystallizing the residue from an organic solvent such as ether or methanol, or by separating and purifying it by column chromatography.

本発明はこのようにして得られた化合物を更に通常の薬
学上許容される技術によって無機酸塩(例えば塩酸、硫
酸、燐酸等)又は有機酸塩(例えば酢酸、マレイン酸、
コハク酸、フマール酸等)に導くことも包含している。
In the present invention, the compound thus obtained can be further treated with an inorganic acid salt (e.g., hydrochloric acid, sulfuric acid, phosphoric acid, etc.) or an organic acid salt (e.g., acetic acid, maleic acid, etc.) by a conventional pharmaceutically acceptable technique.
succinic acid, fumaric acid, etc.).

本発明により得られた化合物は文献未載の新規化合物で
あり、顕著な鎮痛作用、抗炎症作用及び中枢神経抑制作
用等の薬理活性を有し、医薬品として産業上有用な化合
物である。
The compound obtained by the present invention is a new compound that has not been described in any literature, and has pharmacological activities such as remarkable analgesic action, anti-inflammatory action, and central nervous system depressing action, and is an industrially useful compound as a pharmaceutical.

以下に実施例を示し本発明を更に具体的に説明するが、
勿論本発明はこれらのみに限定されるものではない。
The present invention will be explained in more detail with reference to Examples below.
Of course, the present invention is not limited to these.

実施例 1 2−(m−トルイジノ)−3−アミノメチルピリジン4
.3gと尿素12.9を180℃で2時間加熱後200
℃で30時間加熱反応させた。
Example 1 2-(m-toluidino)-3-aminomethylpyridine 4
.. After heating 3g and urea 12.9 at 180℃ for 2 hours, 200
The reaction was carried out by heating at ℃ for 30 hours.

冷後、反応生成物を温水で十分洗浄し残渣をメタノール
より再結晶して、無色プリズム晶の1−(m−)リル)
−2−オキソ−1,2,3,4−テトラヒドロピリド(
2,3−d)ピリミジン2.6gを得た。
After cooling, the reaction product was thoroughly washed with warm water, and the residue was recrystallized from methanol to obtain colorless prismatic crystals of 1-(m-)lyl).
-2-oxo-1,2,3,4-tetrahydropyride (
2,3-d) 2.6 g of pyrimidine were obtained.

この物質の融点及び元素分析値は次の通りであった。The melting point and elemental analysis values of this substance were as follows.

融 点 212〜214°C 元素分析値 C14H1°N30 理論値Cニア0.87 H:4.67 N:17.71
実測値Cニア0.63 H:4.59 N: 17.6
6実施例 2 2− (m−ブロモアニリノ)−3−エチルアミンメチ
ルピリジン2.8gを乾燥テトラヒドロフラン30m1
に溶解後、N、N′−カルボニルジイミダゾールを加え
還流下10時間反応させた。
Melting point 212-214°C Elemental analysis value C14H1°N30 Theoretical value C near 0.87 H: 4.67 N: 17.71
Actual value C near 0.63 H: 4.59 N: 17.6
6 Example 2 2.8 g of 2-(m-bromoanilino)-3-ethylamine methylpyridine was added to 30 ml of dry tetrahydrofuran.
After dissolving the mixture, N,N'-carbonyldiimidazole was added and the mixture was reacted under reflux for 10 hours.

反応終了後、減圧下に溶媒を留去し、残渣に水を加えエ
ーテルで抽出しエーテル層を脱水後アルミナを充填した
カラムに吸着させ、エーテルで展開し溶出液を留去し残
渣をエーテルと石油エーテルの混合溶媒より再結晶して
、無色プリズム晶の1−(m−ブロモフェニル)−3−
エチル−2−、t+ソー1、2.3.4−テトラヒドロ
ピリド(2,3−d)ピリミジン2.2gを得た。
After the reaction, the solvent was distilled off under reduced pressure, water was added to the residue, extracted with ether, the ether layer was dehydrated, adsorbed on a column packed with alumina, developed with ether, the eluate was distilled off, and the residue was extracted with ether. Recrystallization from a mixed solvent of petroleum ether gave colorless prismatic crystals of 1-(m-bromophenyl)-3-
2.2 g of ethyl-2-,t+so-1,2.3.4-tetrahydropyrido(2,3-d)pyrimidine were obtained.

この物質の融点及び元素分析値は次の通りであった。The melting point and elemental analysis values of this substance were as follows.

融 点 108〜110°C 元素分析値 C05H14Br N30 理論値C:54.23 H:4.24 N:12.64
実測値C:54.48 H:4.28 N:12.54
実施例 3 2−(m−フルオロアニリノ)−3−メチルアミノメチ
ルピリジン2.3gを乾燥テトラヒドロフラン30m1
に溶解し、約50%水素化ナトリウム0.96gを加え
室温で30分間攪拌した。
Melting point 108-110°C Elemental analysis value C05H14Br N30 Theoretical value C: 54.23 H: 4.24 N: 12.64
Actual value C: 54.48 H: 4.28 N: 12.54
Example 3 2.3 g of 2-(m-fluoroanilino)-3-methylaminomethylpyridine was added to 30 ml of dry tetrahydrofuran.
About 50% sodium hydride (0.96 g) was added thereto, and the mixture was stirred at room temperature for 30 minutes.

次に氷冷下に約30%の四塩化炭素−ホスゲン溶液10
gを滴下し1時間攪拌した。
Next, under ice-cooling, about 30% carbon tetrachloride-phosgene solution 10
g was added dropwise and stirred for 1 hour.

次に過剰のホスゲンを10%のアセトン−アンモニア溶
液で分解後、減圧下に溶媒を留去し残渣に水を加えエー
テルで抽水、脱水後、アルミナを充填したカラムに吸着
させエーテルで展開し溶出液を濃縮し放置すると、無色
プリズム晶の1−(m−フルオロフェニル)−3−メチ
ル−2−オキソ−1,2,3,4−テトラヒドロピリド
(2,3−d)ピリミジン1.3gを得た。
Next, after decomposing excess phosgene with a 10% acetone-ammonia solution, the solvent was distilled off under reduced pressure, water was added to the residue, extracted with ether, dehydrated, adsorbed on a column packed with alumina, developed with ether, and eluted. When the liquid was concentrated and allowed to stand, 1.3 g of 1-(m-fluorophenyl)-3-methyl-2-oxo-1,2,3,4-tetrahydropyrido(2,3-d)pyrimidine was obtained as colorless prism crystals. I got it.

この物質の融点及び元素分析値は次の通りであった。The melting point and elemental analysis values of this substance were as follows.

融 点 189〜192°C 元素分析値 C14H1□FN30 理論値C:65.36 H:4.70 N:16.33
実測値C: 63.44−H: 4.72 N: 16
.39実施例 4 2− (m −トリフルオロメチルアニリノ)−3−エ
チルアミンメチルピリジン2.0F1ナトリウムエチラ
ート1.0g及びジオキサン30m1の混合物に炭酸ジ
エチル2.4gを攪拌下に滴下した。
Melting point 189-192°C Elemental analysis value C14H1□FN30 Theoretical value C: 65.36 H: 4.70 N: 16.33
Actual value C: 63.44-H: 4.72 N: 16
.. 39 Example 4 2-(m-trifluoromethylanilino)-3-ethylamine methylpyridine 2.4 g of diethyl carbonate was added dropwise to a mixture of 1.0 g of 2.0F1 sodium ethylate and 30 ml of dioxane while stirring.

滴下後、還流下5時間反応させた。After the dropwise addition, the mixture was reacted under reflux for 5 hours.

反応終了後、ジオキサンを減圧下に留去し残渣をエーテ
ルより再結晶して、無色プリズム晶の1−(m−トリフ
ルオロメチルフェニル)−3−エチル−2−オキソ−1
,2,3,4−テトラヒドロピリド(2,3−d)ピリ
ミジン2.1gを得た。
After the reaction, dioxane was distilled off under reduced pressure and the residue was recrystallized from ether to give colorless prismatic crystals of 1-(m-trifluoromethylphenyl)-3-ethyl-2-oxo-1.
, 2.1 g of 2,3,4-tetrahydropyrido(2,3-d)pyrimidine was obtained.

この物質の融点及び元素分析値は次の通りであった。The melting point and elemental analysis values of this substance were as follows.

融 点 155〜157°C 元素分析値 C16H14F3N30 理論値C:59.81 H:4.39 N:13.07
実測値C:59.72 H:4.29 N:13.11
実施例 5 2− (m −トルイジノ)−3−アミノメチルピリジ
ン2.1gをテトラヒドロフラン30m1に溶解後、約
50%の水素化ナトリウム0.5gを加え室温で30分
間攪拌した。
Melting point 155-157°C Elemental analysis value C16H14F3N30 Theoretical value C: 59.81 H: 4.39 N: 13.07
Actual value C: 59.72 H: 4.29 N: 13.11
Example 5 After dissolving 2.1 g of 2-(m-toluidino)-3-aminomethylpyridine in 30 ml of tetrahydrofuran, 0.5 g of about 50% sodium hydride was added and stirred at room temperature for 30 minutes.

次にクロル炭酸エチル3.2gを加え還流下15時間反
応させた。
Next, 3.2 g of ethyl chlorocarbonate was added and reacted under reflux for 15 hours.

反応終了後、減圧下に溶媒を留去し残渣をメタノールよ
り再結晶して、無色プリズム晶の1−(m−トリル)−
2−オキソ−1,2,3,4−テトラヒドロピリド(2
,3−d)ピリミジン1.2gを得た。
After the reaction, the solvent was distilled off under reduced pressure and the residue was recrystallized from methanol to obtain colorless prismatic crystals of 1-(m-tolyl)-
2-oxo-1,2,3,4-tetrahydropyride (2
, 3-d) 1.2 g of pyrimidine was obtained.

融 点 212〜214℃ 実施例 6 2− (m−ヨードアニリノ)−3−エチルアミンメチ
ルピリジン3.5g、乾燥キシレン15m1の溶液にN
、N−ジメチルアミノカルバモイルクロライド1.6g
を加え還流下15時間反応させた。
Melting point 212-214°C Example 6 A solution of 3.5 g of 2-(m-iodoanilino)-3-ethylamine methylpyridine and 15 ml of dry xylene was
, N-dimethylaminocarbamoyl chloride 1.6g
was added and reacted under reflux for 15 hours.

反応終了後、減圧下に溶媒を留去し残渣に水を加えると
油状となった。
After the reaction was completed, the solvent was distilled off under reduced pressure and water was added to the residue to form an oil.

これをクロロホルムで抽出、脱水後、シリカゲルを充填
したカラムに吸着させクロロホルムで展開し、溶出物の
溶媒を留去し残渣をエーテルと石油エーテルの混合溶媒
より再結晶して、無色プリズム晶の1−(m−ヨードフ
ェニル)−3−エチル−2−オキソ−1,2,3,4−
テトラヒドロピリド(2,3−d)ピリミジン0.72
gを得た。
This was extracted with chloroform, dehydrated, adsorbed on a column packed with silica gel, developed with chloroform, the solvent of the eluate was distilled off, and the residue was recrystallized from a mixed solvent of ether and petroleum ether to form colorless prism crystals. -(m-iodophenyl)-3-ethyl-2-oxo-1,2,3,4-
Tetrahydropyrido(2,3-d)pyrimidine 0.72
I got g.

この物質の融点及び元素分析値は次の通りであった。The melting point and elemental analysis values of this substance were as follows.

融 点 137〜139°C 元素分析値 C1,H14■N30 理論値C:47.51 H:3.72 N:11.08
実測値C:47.42 H:3.68 N:11.01
実施例 7 2− (m−ヨードアニリノ)−3−アミノメチルピリ
ジン3.3gを乾燥テトラヒドロフラン30m1に溶解
後、N、N’−カルボニルジイミダゾール3.2Iを加
え還流下12時間反応させた。
Melting point 137-139°C Elemental analysis value C1, H14■N30 Theoretical value C: 47.51 H: 3.72 N: 11.08
Actual value C: 47.42 H: 3.68 N: 11.01
Example 7 After dissolving 3.3 g of 2-(m-iodoanilino)-3-aminomethylpyridine in 30 ml of dry tetrahydrofuran, 3.2 I of N,N'-carbonyldiimidazole was added and reacted under reflux for 12 hours.

反応終了後、減圧下に溶媒を留去し残渣をアセトンに溶
解し、アルミナを充填したカラムに吸着させアセトンで
展開し溶出液を濃縮し放置すると、無色針状晶の1−(
m−ヨードフェニル)−2−オキソ−1,2,3,4−
テトラヒドロピリド(2,3−d)ピリミジン2,5g
を得た。
After the reaction is complete, the solvent is distilled off under reduced pressure, the residue is dissolved in acetone, adsorbed on a column packed with alumina, developed with acetone, the eluate is concentrated, and when left to stand, colorless needle crystals of 1-(
m-iodophenyl)-2-oxo-1,2,3,4-
Tetrahydropyrido(2,3-d)pyrimidine 2.5g
I got it.

この物質の融点及び元素分析値は次の通りであった。The melting point and elemental analysis values of this substance were as follows.

融 点 175〜177°C 元素分析値 C13H1oIN30 理論値C:44.46 H:2.87 N:11.97
実測値C: 44.32 H: 2.78 N: 11
.88実施例 8 実施例4における2−(m−トリフルオロメチルアニリ
ノ)−3−エチルアミンメチルピリジンの代わりに2−
(p−フルオロアニリノ)−3−メチルアミノメチルピ
リジンを、炭酸ジエチルの代わりにピロ炭酸ジエチルを
用いて実施例4と同様に操作することによって、無色針
状晶の1−(p−フルオロフェニル)−3−メチル−2
−オキソ−1,2,3,4−テトラヒドロピリド(2、
3−d〕ピリミジンを得た。
Melting point 175-177°C Elemental analysis value C13H1oIN30 Theoretical value C: 44.46 H: 2.87 N: 11.97
Actual measurement value C: 44.32 H: 2.78 N: 11
.. 88 Example 8 In place of 2-(m-trifluoromethylanilino)-3-ethylaminemethylpyridine in Example 4, 2-
(p-Fluoroanilino)-3-methylaminomethylpyridine was prepared in the same manner as in Example 4 using diethyl pyrocarbonate instead of diethyl carbonate to produce colorless needles of 1-(p-fluorophenyl pyridine). )-3-methyl-2
-oxo-1,2,3,4-tetrahydropyride (2,
3-d]pyrimidine was obtained.

融 点 212〜213℃ 実施例 9 2−(3,4−ジクロロアニリノ)−3−メチルアミン
メチルピリジン2.5gをジオキサン30m1に溶解後
、約50%の水素化ナトリウム1.0gを加え室温で3
0分間攪拌後、炭酸ジエチル2.4gを加え、次に還流
下4時間反応させた。
Melting point 212-213°C Example 9 2-(3,4-dichloroanilino)-3-methylamine 2.5 g of methylpyridine was dissolved in 30 ml of dioxane, and 1.0 g of about 50% sodium hydride was added at room temperature. So 3
After stirring for 0 minutes, 2.4 g of diethyl carbonate was added, and the mixture was reacted under reflux for 4 hours.

反応終了後、溶媒を減圧下に留去し残渣をエーテルより
再結晶して、無色針状晶の1−(3,4〜ジクロロフエ
ニル)−3−メチル−2−オキソ−1,2,3,4−テ
トラヒドロピリド(2,3−d〕ピリミジン2.6gを
得た。
After the reaction, the solvent was distilled off under reduced pressure and the residue was recrystallized from ether to give colorless needle-like crystals of 1-(3,4-dichlorophenyl)-3-methyl-2-oxo-1,2, 2.6 g of 3,4-tetrahydropyrido(2,3-d)pyrimidine was obtained.

この物質の融点及び元素分析値は次の通りであった。The melting point and elemental analysis values of this substance were as follows.

融 点 149〜150°C 元素分析値 C14H1□Cl2N30 理論値C:54.56 H:3.59 N:13.63
実測値C: 54.42 H: 3.51 N: 13
.58実施例 10 102−(クロロアニリノ)−3−(2−エトキシエチ
ル)アミノメチルピリジン3.1gをジオキサンに溶解
後、約50%の水素化ナトリウムIgを加え室温で30
分間攪拌した。
Melting point 149-150°C Elemental analysis value C14H1□Cl2N30 Theoretical value C: 54.56 H: 3.59 N: 13.63
Actual measurement value C: 54.42 H: 3.51 N: 13
.. 58 Example 10 After dissolving 3.1 g of 102-(chloroanilino)-3-(2-ethoxyethyl)aminomethylpyridine in dioxane, approximately 50% sodium hydride Ig was added and the mixture was heated to 30% at room temperature.
Stir for a minute.

次にN、N’−カルボニルジイミダゾール3.2gを加
え室温で1時間、還流下5時間反応させた。
Next, 3.2 g of N,N'-carbonyldiimidazole was added and reacted for 1 hour at room temperature and for 5 hours under reflux.

反応終了後、減圧下に溶媒を留去し残渣に水を加えエー
テルで抽出、脱水後、アルミナを充填したカラムに吸着
させエーテルで展開し、溶出液を濃縮し放置すると、無
色プリズム晶の1−(m−クロロフェニル)−3−(2
−エトキシエチル)−2−オキソ−1,2゜3.4−テ
トラヒドロピリド(2,3−d)ピリミジン2.6gを
得た。
After the reaction, the solvent was distilled off under reduced pressure, water was added to the residue, extracted with ether, dehydrated, adsorbed on a column packed with alumina, developed with ether, concentrated the eluate, and left to stand, resulting in colorless prism crystals. -(m-chlorophenyl)-3-(2
2.6 g of -ethoxyethyl)-2-oxo-1,2°3.4-tetrahydropyrido(2,3-d)pyrimidine was obtained.

この物質の融点及び元素分析値は次の通りであった。The melting point and elemental analysis values of this substance were as follows.

融 点 100〜101°C 元素分析値 C1□H18CIN30□ 理論値C:61.54 H:5.46 N:12.66
実測値C:61.48 H:5.43 N:12.59
実施例 11〜120 実施例1〜10の方法に準じて次表の化合物を合成した
Melting point 100-101°C Elemental analysis value C1□H18CIN30□ Theoretical value C: 61.54 H: 5.46 N: 12.66
Actual value C: 61.48 H: 5.43 N: 12.59
Examples 11-120 The compounds shown in the following table were synthesized according to the methods of Examples 1-10.

Claims (1)

【特許請求の範囲】 (式中、R1は(1)フェニル基、(2)ハロゲン原子
、低級アルキル基、低級アルコキシ基、ニトロ基又はト
リフルオロメチル基で置換されたフェニル基を、R2は
(1)水素原子、(2)低級アルキル基、(3)ハロゲ
ン原子、低級シクロアルキル基、水酸基、アルコキシ基
、アセトキシ基、フェニル基又はアミノ基で置換された
低級アルキル基、(4)アルケニル基又は(5)アルキ
ニル基を意味する)で表わされる化合物に一般式 (式中、Xはハロゲン原子、アルコキシ基又はアミノ基
を、Yはハロゲン原子、トリハロアルキル基、アルコキ
シ基、アリールオキシ基、アルコキシカルボニルオキシ
基、アシルオキシ基又はアミノ基を意味する)で表わさ
れる化合物を反応させることを特徴とする一般式 (式中、R1及びR2は前記と同じ釡味を有する)で表
わされる新規な2−オキソ−1,2,3,4−テトラヒ
ドロピリド〔2,3−d)ピリミジン誘導体及びその酸
付加塩の製造法。
Claims: (In the formula, R1 is (1) a phenyl group, (2) a phenyl group substituted with a halogen atom, a lower alkyl group, a lower alkoxy group, a nitro group, or a trifluoromethyl group, and R2 is ( 1) hydrogen atom, (2) lower alkyl group, (3) lower alkyl group substituted with a halogen atom, lower cycloalkyl group, hydroxyl group, alkoxy group, acetoxy group, phenyl group or amino group, (4) alkenyl group, or (5) Means an alkynyl group) is a compound represented by the general formula (wherein, A novel 2-oxo compound represented by the general formula (wherein R1 and R2 have the same properties as above) is reacted with a compound represented by an oxy group, an acyloxy group, or an amino group. -1,2,3,4-tetrahydropyrido[2,3-d) A method for producing a pyrimidine derivative and an acid addition salt thereof.
JP49091202A 1974-06-12 1974-08-07 Synquina 2-oxo-1,2,3,4-tetrahydropyride (2,3-D) Pyrimidine Expired JPS58429B2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP49091202A JPS58429B2 (en) 1974-08-07 1974-08-07 Synquina 2-oxo-1,2,3,4-tetrahydropyride (2,3-D) Pyrimidine
NL7506720A NL7506720A (en) 1974-06-12 1975-06-06 2- or 4-oxo-1,2,3,4-tetrahydropyrido(2,3-d)pyrimidins - with e.g. anti-inflammatory analgesic and CNS-depressive activity
SE7506575A SE420609B (en) 1974-07-05 1975-06-09 ANALOGY PROCEDURE FOR PREPARATION OF 2-OXO-1,2,3,4-TERAHYDROPYRIDO (2,3-D) PYRIMIDINES
CH815975A CH614207A5 (en) 1974-07-05 1975-06-24 Process for the preparation of 2-oxo-1,2,3,4-tetrahydropyrido[2,3-d]pyrimidine
CA75230890A CA1048496A (en) 1974-07-05 1975-07-07 Process for preparing 2-oxo-1,2,3,4-tetrahydropyrido (2,3-d) pyrimidines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP49091202A JPS58429B2 (en) 1974-08-07 1974-08-07 Synquina 2-oxo-1,2,3,4-tetrahydropyride (2,3-D) Pyrimidine

Publications (2)

Publication Number Publication Date
JPS5123296A JPS5123296A (en) 1976-02-24
JPS58429B2 true JPS58429B2 (en) 1983-01-06

Family

ID=14019835

Family Applications (1)

Application Number Title Priority Date Filing Date
JP49091202A Expired JPS58429B2 (en) 1974-06-12 1974-08-07 Synquina 2-oxo-1,2,3,4-tetrahydropyride (2,3-D) Pyrimidine

Country Status (1)

Country Link
JP (1) JPS58429B2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6025257A (en) * 1983-07-21 1985-02-08 Fujitsu Ltd Semiconductor device
JPH051617B2 (en) * 1984-02-10 1993-01-08 Mitsubishi Electric Corp

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1300744C (en) * 1988-03-25 1992-05-12 Peter Eduard Haferl Arrangement for reducing ringing in a flyback transformer

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6025257A (en) * 1983-07-21 1985-02-08 Fujitsu Ltd Semiconductor device
JPH051617B2 (en) * 1984-02-10 1993-01-08 Mitsubishi Electric Corp

Also Published As

Publication number Publication date
JPS5123296A (en) 1976-02-24

Similar Documents

Publication Publication Date Title
US3227721A (en) Process for preparing 2-methyl-3-hydroxypyridines
JPS58429B2 (en) Synquina 2-oxo-1,2,3,4-tetrahydropyride (2,3-D) Pyrimidine
JPS5854152B2 (en) Novel naphthyridine derivatives
JPS5920676B2 (en) Method for producing a novel pyrimido[4,5-d]pyrimidine derivative
JPS5813550B2 (en) Sinquinapiride (4,3-D) Pyrimidinedione
JPS5813551B2 (en) Sinquinapiride (4,3-D) Pyrimidinedione
US3246010A (en) 1, 5-diaryl-2-pyrrole propanols and ethers
JPS582950B2 (en) Sinquinapyridopyrimidinedione
JPS5920677B2 (en) Method for producing a novel pyrimido[4,5-d]pyrimidinedione derivative
JPS5920674B2 (en) Pyrido (2,3-D) Pyrimidine
KR800000748B1 (en) Process for preparing 2-oxo-1,2,3,4-tetrahydro-pyrido(2,3)pyrimidin derivatives
JPS5829792B2 (en) Sinquinapiride (4,3-D) Pyrimidinedione
JPS5920675B2 (en) Method for producing a novel pyrimido[4,5-d]pyrimidine derivative
US3642791A (en) Morpholino-1-substituted-2(1h)-quinazolinones
JPS5813545B2 (en) Sinquinapiride % 2 3 - D @ pyrimidinedione
JPS5813547B2 (en) Cinquinapiride (2,3-D) Pyrimidinedione
JPS582947B2 (en) Sinquinapyridopyrimidinedione
JPS584033B2 (en) Method for producing a novel pyrido[2,3-d]pyrimidine-2-thione derivative
JPS5827278B2 (en) Synquina 4-oxo-1,4-dihydropyrido (2,3-D) Pyrimidine
JPS58432B2 (en) Cinquinapiride -1,4- Diazepine
JPS5995286A (en) Imidazo(4,5-c)pyridine-6-carboxylic acid derivative
JPS582953B2 (en) How to use pyridopyrimidine dione
JPS582952B2 (en) Sinquinapiride (23-D) Pyrimidinethione
JPS5830317B2 (en) Cinquinapiride (2,3-D) Pyrimidinedione
JPS5813549B2 (en) 2-oxo-1,2,3,4-tetrahydropyrido (2,3-D) pyrimidine